ECNS 📈 iShares MSCI China Small-Cap - Overview

Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US46429B2007 • China Region

ECNS: Chinese, Small-Cap, Stocks, Equities

The fund generally will invest at least 80% of its assets in the component securities of the underlying index and in investments that have economic characteristics that are substantially identical to the component securities of the underlying index. The index is a free float-adjusted market capitalization-weighted index that is designed to measure the performance of the small-capitalization segment of the Chinese equity securities markets, as represented by the H-shares and B-shares markets. ‣ Company URL: http://www.ishares.com ‣ Domicile: United States

Additional Sources for ECNS ETF

ECNS ETF Overview

Market Cap in USD 62m
Category China Region
TER 0.59%
IPO / Inception 2010-09-28

ECNS ETF Ratings

Growth 5y -27.3%
Fundamental -
Dividend 27.4%
Rel. Strength Industry -60.2
Analysts -
Fair Price Momentum 24.38 USD
Fair Price DCF -

ECNS Dividends

Dividend Yield 12m 1.88%
Yield on Cost 5y 1.50%
Annual Growth 5y -0.97%
Payout Consistency 84.7%

ECNS Growth Ratios

Growth Correlation 3m -39.2%
Growth Correlation 12m 50.3%
Growth Correlation 5y -71.7%
CAGR 5y -4.42%
CAGR/Mean DD 5y -0.13
Sharpe Ratio 12m 0.34
Alpha -9.13
Beta 0.66
Volatility 34.22%
Current Volume 4.2k
Average Volume 20d 12.2k
What is the price of ECNS stocks?
As of December 27, 2024, the stock is trading at USD 25.77 with a total of 4,200 shares traded.
Over the past week, the price has changed by +2.74%, over one month by +5.42%, over three months by +12.55% and over the past year by +11.15%.
Is iShares MSCI China Small-Cap a good stock to buy?
Probably not. Based on ValueRay Analyses, iShares MSCI China Small-Cap (NYSE ARCA:ECNS) is currently (December 2024) not a good stock to buy. It has a ValueRay Growth Rating of -27.25 and therefor a somwhat technical negative rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of ECNS as of December 2024 is 24.38. This means that ECNS is currently overvalued and has a potential downside of -5.39%.
Is ECNS a buy, sell or hold?
iShares MSCI China Small-Cap has no consensus analysts rating.
What are the forecast for ECNS stock price target?
According to ValueRays Forecast Model, ECNS iShares MSCI China Small-Cap will be worth about 26.8 in December 2025. The stock is currently trading at 25.77. This means that the stock has a potential upside of +4.07%.
Issuer Forecast Upside
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 26.8 4.1%